The post-translational proteolytic conversion of somatostatin-14 precursors was studied to characterize the enzyme system responsible for the production of the tetradecapeptide either from its 15-kDa precursor protein or from its COOH-terminal fragment, somatostatin-28. A synthetic undecapeptide Pro-Arg-Glu-Arg-Lys-Ala-Gly-Ala-Lys-AsnTyr(NH2), homologous to the amino acid sequence of the octacosapeptide at the putative Arg-Lys cleavage locus, was used as substrate, after 125I labeling on the COOH-terminal tyrosine residue. A 90-kDa proteolytic activity was detected in rat brain cortex extracts after molecular sieve fractionation followed by ion exchange chromatography. The protease released the peptide 1251-Ala-Gly-Ala-Lys-Asn-Tyr(NH2) from the synthetic undecapeptide substrate and converted somatostatin-28 into somatostatin-14 under similar conditions (pH 7.0). Under these experimental conditions, the product tetradecapeptide was not further degraded by the enzyme. In contrast, the purified 15-kDa hypothalamic precursor remained unaffected when exposed to the proteolytic enzyme under identical conditions. It is concluded that this Arg-Lys esteropeptidase from the brain cortex may be involved in the in vivo processing of the somatostatin-28 fragment of prosomatostatin into somatostatin-14, the former species being an obligatory intermediate in a two-step proteolytic mechanism leading to somatostatin-14.
the peptide 1251-Ala-Gly-Ala-Lys-Asn-Tyr(NH2) from the synthetic undecapeptide substrate and converted somatostatin-28 into somatostatin-14 under similar conditions (pH 7.0). Under these experimental conditions, the product tetradecapeptide was not further degraded by the enzyme. In contrast, the purified 15-kDa hypothalamic precursor remained unaffected when exposed to the proteolytic enzyme under identical conditions. It is concluded that this Arg-Lys esteropeptidase from the brain cortex may be involved in the in vivo processing of the somatostatin-28 fragment of prosomatostatin into somatostatin-14, the former species being an obligatory intermediate in a two-step proteolytic mechanism leading to somatostatin-14.
A number of neural, or hormonal, peptides have been shown to derive biosynthetically from larger molecular weight precursors by post-translational proteolytic cleavage. Elucidation of the amino acid sequences of many of these proforms has clearly underlined the importance of basic amino acid doublets as potential recognition sites for selective proteases. In addition, putative cleavage points corresponding either to a lone lysine or arginine residue, as well as double pairs of basic amino acids, were deduced from the established primary structures of some precursors (1) (2) (3) (4) (5) (6) (7) . Although structural information on these potential cleavage points is available, little is known at this time about the enzymes involved in recognition of these sites.
The predicted sequences of the prosomatostatins from pancreatic tissue (2) have indicated that the tetradecapeptide somatostatin-14 occupies the COOH-terminal end of the precursor and that an Arg-Lys doublet can be found at position -2, -1 from the NH2 terminus of the somatostatin-14 se- quence. Furthermore, the finding in both hypothalamic and pancreatic tissues of octacosapeptides called somatostatin-28 (8) (9) (10) (11) has suggested that the lone arginine residue observed in the precursor (at position -15 from the NH2-terminal alanine of somatostatin-14) may constitute the recognition signal for a specific protease responsible for the release of somatostatin-28. Therefore, prosomatostatin offers a model particularly well suited for the study of the proteolytic systems involved in the processing of proneuropeptides and exhibiting a specificity either for basic amino acid doublets and/or for a lone arginine residue.
In the hypothalamus, the presence of a 15-kDa immunoreactive form of somatostatin was established by immunochemical analysis of either mouse organ extracts (12, 13) or mRNA translation products (14) . Its conversion to both somatostatin-14 and somatostatin-28 by crude hypothalamic extracts was achieved in vitro, demonstrating that it is a potential common precursor to both tetradecapeptide and octacosapeptide (12, 13, 15) . To characterize the type of endopeptidase that exhibits a selectivity for stretches of basic amino acids and that is possibly involved in the in vivo production of somatostatin-14 from either its 15-kDa or somatostatin-28 precursors, we have synthesized a peptide substrate. This undecapeptide mimics the amino acid sequence situated on both sides of the Arg-Lys doublet shared both by the 15-kDa precursor and by somatostatin-28. We report here on the detection in brain cortex extracts of an Arg-Lys esteropeptidase. This protease is able to cleave either the synthetic undecapeptide or somatostatin-28 by hydrolysis of the peptide bond situated on the -C-side of the lysine 1 1 0 residue. This observation is discussed in connection with the possible role of such a selective enzyme in the biosynthetic pathways leading to somatostatin-14.
MATERIALS AND METHODS Wistar male rats (100-120 g) were sacrificed by rapid decapitation and the cerebral cortex was immediately removed. The freshly dissected tissue was homogenized in a PotterElvehjem homogenizer in 50 mM phosphate buffer, pH 7.4/200 mM KCl (5 ml of buffer per cortex). The extract was then centrifuged for 15 min at 3000 x g in a refrigerated Beckman TJ-6 centrifuge, and the supernatant was filtered on a Sephadex G-150 column in 0.25 M Tris HCl (pH 7). The fractions exhibiting the proteolytic activity were then pooled and submitted to ion exchange chromatography on a Mono Q (cationic) column using a fast protein liquid chromatography system (Pharmacia, Uppsala, Sweden).
Peptides I and II (see Results) were synthesized by an improved procedure of the solid-phase method (16) The HPLC system consisted of an SP 8000 (Spectra Physics, Santa Clara, CA) apparatus. A reversed-phase ,Bondapak C18 column (300 x 3.0 mm; Waters Associates) eluted at a flow rate of 1 ml min-1 was used. Elution was performed isocratically by a mixture of 25% acetonitrile in aqueous formic acid (1.15%) adjusted to pH 3 with triethylamine phosphate.
Radioimmunoassay was done using antiserum 36-38 directed toward the COOH-terminal portion of somatostatin-14 as described (12, 13 Pro-Arg-Glu-Arg-Lys-Ala-Gly-Ala-Lys-Asn-125I-Tyr(NH2) [peptide I].
A partially purified extract from rat brain cortex provided a source of converting enzyme activity. The rationale for the choice of both substrate structure and enzyme source was as follows. (i) The undecapeptide primary structure mimics the sequence of hypothalamic somatostatin-28 around the ArgLys putative cleavage signal (9-11) 1 5 10 Ser-Ala-Asn-Ser -Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys- 15 20 25 Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp -Lys-Thr-Phe-Thr-Ser-Cys.
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(ii) The Tyr1" side chain provides a site for 1251 labeling, allowing a sensitive and rapid detection of the generated reaction product without altering the possible requirement of the protease for an aromatic residue (Phe20 of the somatostatin-28 sequence). Preliminary evaluation of the converting activities in three brain areas indicated that the hypothalamus, a major site for somatostatin and other neuropeptide production, contained a high level of substrate degradation activity. In contrast, the neocortex, an area known to possess both intrinsic as well as hypothalamic-derived axon terminals of somatostatinergic neurons (19) appeared to be more adequate for the enzymatic analysis of the selective cleavage ( Table 1) . Extracts of rat brain cortex were incubated with peptide I at pH 7 and 370C. At the end of the incubation, the reaction products were analyzed by ion exchange. The expected generated peptide Ala-Gly-Ala-Lys-Asn-125I-Tyr(NH2) [ peptide II], and the starting material were eluted from the CM52 column by ammonium acetate concentrations of 80 mM and 200 mM as assessed separately using both reference synthetic peptides I and II (Fig. 1) . In contrast, the final product of a contaminant degrading activity, Asn-125I-Tyr(NH2) was not retained by the resin under these conditions. Peptides generated by cleavage either between residues 5 and 6 or 9 and 10 of peptide I carry distinct net charges and behave in a different manner on such an ion exchange. Thus, this procedure allows a rapid and quantitative discrimination between both Fig. 2A) . A 50-,ul aliquot of peak a activity (obtained as in Fig. 2A ) was incubated with peptide I (20,000 cpm) for 2 hr, and the products were analyzed as described in Fig. 1 The somatostatin converting activity of the brain cortex extract was partially purified by molecular sieve filtration on a Sephadex G-150 column (Fig. 2A) . A specific cleaving activity was found associated with fractions eluting as species with a size approximating 90 kDa. The products generated by this particular enzyme fraction were characterized by NH2-terminal determination using the double-coupling method described (18) . Results demonstrated the presence of a single alanine residue at the NH2 terminus of the peptide eluted on the ion exchange column by ammonium acetate, ranging from 30 to 100 mM (peptide II).
On this fractionation, another peak of proteolytic activity, with an apparent size of 46 kDa, was separated ( Fig. 2A) . Peptide I was also converted by this fraction into peptide II, but to a much lower extent (Fig. 2A) . In addition to this major proteolytic activity, another protease was detected in fractions eluted as a 60-kDa species. This appeared to correspond to a degrading activity generating the dipeptide fragment Asn-125I-Tyr(NH2) as assessed both by ion exchange chromatography and by NH2-terminal analysis. The 90-kDa fraction was therefore submitted to ion exchange chromatography on a cationic resin. Fig. 2B indicates that the activity eluted between 80 and 120 mM NaCl was essentially free of the contaminating degrading activity. This protease fraction was subsequently used as a source of converting activity in all the experiments described below.
The enzyme was found to be stable when stored at 40C and retained its full activity for several days under these conditions. The optimum condition for this specific activity was around pH 7 with a rapid decline below pH 6 (not shown). The reaction was linear, with respect to the amount of total protein up to 200 ,ug of protein per assay. Kinetic studies were carried out to determine the effect of various substrate concentrations on the reaction rate. The proteolytic activity behaved in a Michaelis-Menten manner with peptide I as substrate (Fig. 3) . Under these conditions, a Km of 20 x 10l M and a Vmax of 2.1 pmol ,ugg per hr were measured. This activity was inhibited both by iodoacetamide at 2.7 mM (100% inhibition) and by diisopropylfluorophosphate at 6 mM (25% inhibition). No effect was detected when the soybean trypsin inhibitor (20 ,uM) was added to the protease assay.
Final demonstration for the selectivity of this esteropepti- 7 ) and submitted to an ion exchange chromatography on a Mono Q column, using the fast protein liquid chromatography system. The proteins were eluted by a NaCl gradient. Converting activity was assayed on a 50-,ul aliquot of each fraction (1 ml) incubated with '25I-labeled peptide I (30,000 cpm) at 37°C, pH 7.0, for 3 hr. The Arg-Lys esteropeptidase activity was eluted between 80 and 120 mM NaCl. dase was achieved using somatostatin-28 as substrate. The somatostatin-like products generated by the reaction were analyzed by RIA coupled to HPLC, because the procedure allowed a total separation of somatostatin-14 from somatostatin-28 in a single run (Fig. 4A) . Reversed-phase HPLC analysis indicated (Fig. 4B) that >55% of the starting somatostatin-28 immunoreactive material was converted into species indistinguishable from synthetic reference somatostatin-14 (retention time, 22 min). No degradation of the generated somatostatin-14 was observed under these conditions, because >98% of the starting somatostatin-like immunoreactivity was recovered at the end of the reaction. Under similar conditions, the 15-kDa hypothalamic prosomatostatin form was recovered unmodified when exposed to the protease preparation. On the other hand, when incubation was made using the 60-kDa degrading enzyme fraction (from Fig. 2A) , no significant amount of somatostatin-14 was generated (Fig.  4C ).
DISCUSSION
The 15-kDa and somatostatin-28 immunoreactive forms of somatostatin appear to be associated with somatostatin-14 in both rat brain cortex (20) and cerebral cortical cells (21) . A precursor role for these high molecular weight species was inferred from observations made with crude extracts (12, 22) and from attempts to detect the relevant proteases (12, 22) . In these reports, the hypothalamus was chosen as a source of enzyme. In most cases the converting activity, which was found associated with crude synaptosomes, led generally to a rapid degradation of the somatostatin-28 into unidentified products with low yields of somatostatin-14 (23) . The present enzyme preparation after partial purification shows both a great specificity toward the cleavage signal and generates a single stable product-i.e., somatostatin-14. Only a single alanine residue was found at the NH2 terminus of both the generated somatostatin-14 and peptide II, no lysine or arginine could be detected at this position of the cleavage products. This suggests that the converting activity detected in the cortex acts as an Arg-Lys esteropeptidase with a strict selectivity for the lysine -C-peptide bond.
The sensitivity of the peptidase to thiol reagents could be taken as suggestive of a role for SH moieties at the active site. Most of the processing enzyme activities reported up to (Fig. 2B) , (C) fraction 53 ( Fig. 2A) . The mixture was then treated and analyzed. (A) More than 98% of the starting somatostatin-28 immunoreactive material was recovered as unchanged somatostatin-28. (B) The converting activity fractions from the fast protein liquid chromatography elution (Fig. 2B) were used as source of enzyme: 55% of somatostatin-14 was produced and 45% of unmodified somatostatin-28 was recovered in the mixture. (C) Peak b from the gel filtration ( Fig. 2A) was used as source of enzyme: 50% degradation of the starting material was observed and no somatostatin-14 could be detected. Results are expressed in ng of somatostatin immunoreactivity per fraction (1 ml). S-28, somatostatin-28; S-14, somatostatin-14. now show suggestive evidence for this type of active-site residue involvement (24) (25) (26) (27) .
In a number of hormone production systems, processing associated with the cleavage of basic doublets was reported (25) (26) (27) (28) . Although the detailed mechanism of such enzyme action still remains obscure, the sequential involvement of trypsin-like, followed by carboxypeptidase B-like, enzymes was invoked (29) . In the present model, the production of somatostatin-14 results from the hydrolysis of a peptide bond on the lysine -C-side of the Arg-Lys doublet 1 1 belonging to somatostatin-28. However, release of the NH2-terminal fragment of somatostatin-28 (residues 1 --12) (30), which implies the removal of the Arg-Lys doublet from the COOH terminus, may involve carboxypeptidase-like enzymes. Therefore, a more detailed structural analysis of the putative 1 --14 fragment on the NH2-terminal side of the Arg-Lys doublet is needed.
Interestingly the 15-kDa hypothalamic prosomatostatin, which possesses the somatostatin-28 sequence at its COOHterminal end, including the Arg-Lys doublet (positions [13] [14] of somatostatin-28), was not processed by the activity conBiochemistry: Gluschankof et aL 6666 Biochemistry: Gluschankof et al.
verting somatostatin-28 into somatostatin-14 under identical experimental conditions. The possibility that this failure may be due to the experimental conditions cannot be excluded. In particular, if another enzyme involved in the direct conversion of 15-kDa prosomatostatin into somatostatin-14 exists and is associated with another cell compartment, extraction conditions may become critical. Conformational restrictions at the Arg-Lys doublet occurring in the 15-kDa precursor can also be invoked. If this were the case in vivo, prior conversion of the 15-kDa precursor into somatostatin-28 could be an obligatory step in the enzymatic cascade leading to somatostatin-14. Relevant to this hypothesis is our recent observation in anglerfish pancreatic islets that the (tyrosine-7, glycine-10) derivative of somatostatin-14 is included in a somatostatin-28 II form, which is not processed in vivo into the tetradecapeptide (31) . But in vitro generation of this somatostatin analog, called somatostatin-14 IT (2) , was obtained by exposure of the somatostatin-28 II form to the brain cortex esteropeptidase preparation (31) . Hence, the protease involved in the production of somatostatin-28 from prosomatostatin, which can be hypothesized as being different from the Arg-Lys esteropeptidase herein described, remains to be discovered.
Comparison of the amino acid sequences present around the putative cleaving signal in the established sequences of several precursors (1-7) does not reveal striking homologies. Thus, the possibility that the converting activity described here may be involved in the processing of other precursor sequences associated with doublet basic amino acids must be considered. Regional and subcellular distribution of this activity, together with studies of synthetic substrates reproducing the sequence around the cleavage locus of known peptide precursors, may provide a powerful tool to answer these questions. 
